A3Z-26379-40762
4 vaccinations
1 coded response
13 check-ins
0 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 902 / CA
- Registered
- 2021-11-07
- Relationship
- Self
- Race
- Black or African American
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-10-01
Dose 1 — Pfizer-BioNTech
-
2021-10-28
Dose 2 — Pfizer-BioNTech
-
2021-11-07
Registered in v-safe
- 2021-11-07
- 2021-11-11
- 2021-11-20
- 2021-11-27
- 2021-12-03
- 2021-12-09
- 2022-01-27
-
2022-02-10
Dose 3 — Pfizer-BioNTechCo-administered: Flu
- 2022-03-19
- 2022-03-24
- 2022-05-12
-
2022-05-25
Dose 4 — Pfizer-BioNTechCo-administered: Flu
- 2022-08-24
- 2022-11-24
-
2023-05-25
Survey response — 12 months, dose 4MedDRA: Dyspnoea — Feeling: Fair · Be unable to do your normal daily activitiesMedDRA releases: 2024-11
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-10-01 | Pfizer-BioNTech | No |
| 2 | 2021-10-28 | Pfizer-BioNTech | No |
| 3 | 2022-02-10 | Pfizer-BioNTech | Flu |
| 4 | 2022-05-25 | Pfizer-BioNTech | Flu |
Free text
None.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Dyspnoea | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release